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ABTRACT 
 This master’s thesis focuses on how disruption of fatty acid metabolism 
affects both host adaptation and immune evasion in the deadly eukaryotic 
parasite, Trypanosoma brucei. In Chapter 1, I review the current literature on 
African trypanosomiasis, fatty acid synthesis, immune evasion, and lipid 
metabolism. In Chapter 2, I investigate how disruption of the fatty acid synthesis 
pathway affects the parasite’s ability to evade the host immune defenses. When 
T. brucei acetyl-CoA carboxylase (TbACC) is knocked down by RNA interference 
(RNAi), fluid phase and receptor mediated endocytosis pathways are greatly 
affected, suggesting that fatty acid synthesis is necessary for both endocytic 
pathways. Further, the parasite’s ability to clear surface immune antigens was 
reduced under ACC-RNAi conditions. In Chapter 3, I begin to elucidate the 
connection between fatty acid synthesis, fatty acid uptake, and lipid storage. 
ACC-RNAi caused a significant reduction in the number of lipid droplets. This 
effect can be reversed by the addition of external fatty acids, suggesting that lipid 
droplets are possibly a sorting site for both internally synthesized fatty acids as 
well as fatty acids taken up from the environment. Therefore, fatty acids are 
believed to be internalized to the ER, transferred to the lipid droplet, and then 
incorporated into the fatty acid synthesis pathway, where they can be utilized 
within the cell or returned to the lipid droplet. These studies serve as a 
preliminary linkage between fatty acid metabolism and host-parasite interaction, 
which is needed to fully understand T. brucei and bring forth a new cure. 
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CHAPTER ONE 
LITERATURE REVIEW 
AFRICAN TRYPANOSOMIASIS 
 African trypanosomiasis is caused by the early branching eukaryotic 
parasite, Trypanosoma brucei. The parasite is transmitted to the mammalian host 
through the bite of the tse tse fly. There are 3 subspecies and a closely related 
species that infect either humans or livestock, such as cattle. The two subspecies 
that infect humans are T. brucei gambiense and T. brucei rhodesiense. T. b. 
gambiense is found on the western side of the Nile rift valley, accounts for 95% 
of infections, and causes a chronic infection leading to death in approximately 3 
years. T. b. rhodesiense is found on the eastern side of the Nile rift valley, 
accounts for 5% of infections, and causes an acute infection, where death can 
occur in as little as 3 weeks (Brun et al., 2010).  
 African trypanosomiasis also attributes to significant livestock loss; the 
resulting disease, nagana, causes wasting disease in cattle. It is estimated that 
~$4.5 billion dollars are lost annually due to nagana. The infectious subspecies of 
livestock include T. brucei brucei and the related species, T. congolense. 
Humans are not infected by T. b. brucei because all humans possess a high 
density lipoprotein, trypanolytic factor (TLF), which serves as part of our innate 
immunity. TLF lyses the parasite when it is taken up via endocytosis by the 
parasite within the human bloodstream (Wheeler, 2010). Therefore, T. b. brucei 
is used in laboratory settings as a study organism.   
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 Approximately 6.2 million square miles of sub-Saharan Africa is at risk for 
the fatal disease in humans (FAO, Food and Agricultural Administration of the 
United Nations, 2007). From 1998-2004, there were an estimated 50,000-70,000 
cases annually (WHO, 2012). Subsequently, since 2009 and the WHO’s 
implementation of alternative treatment methods, such as insect repellent and 
nets, that number has declined to under 10,000 reported cases annually (WHO, 
2012). However, the number of annually reported cases is likely a low estimate 
due to civil unrest and the general lack of infrastructure, which plagues much of 
sub-Saharan Africa. In some regions, the rate of human African trypanosomiasis 
(HAT) or sleeping sickness remains especially high, causing greater morbidity 
and mortality than HIV/AIDS or malaria (WHO, 2012). 
 HAT manifests itself in two distinct clinical stages. Early-stage infections 
are characterized by fever, swollen lymph nodes, and headache, if symptoms are 
even present. The parasites are limited to the bloodstream and lymph during this 
stage. Late-stage infections are far more severe and are characterized by 
worsening symptoms, including severe insomnia and disruptions in circadian 
rhythms, causing a lethargic coma-like state, lending to the origin of its more 
common name, “sleeping sickness.” Parasites in late-stage infections have 
crossed the blood-brain barrier and are present in the central nervous system 
(brain and cerebral spinal fluid (CSF)) (Brun, et al., 2010).  
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T. brucei Lifecycle 
 T. brucei alternates between two hosts, the mammal and the tse tse fly. 
The parasite is transmitted to the mammal from an infected tse tse fly’s bite. The 
mammalian bloodstream form parasites (BFs) live extracellularly in the 
bloodstream, where they proliferate by binary fission. BFs can cross the blood-
brain barrier, resulting in coma and eventually death. The BFs remaining in the 
bloodstream differentiate into non-proliferative “short stumpy” forms. These “short 
stumpy” forms are primed to re-enter the tse tse fly.  
 When a tse tse fly bites an infected mammal, it picks up the “short stumpy” 
form parasites in the blood meal. These parasites will differentiate into the 
proliferative procyclic forms (PFs) and undergo a short proliferation stage in the 
midgut. Then, they exit the midgut, traversing the midgut wall, where they travel 
through the hemolymph to the salivary glands. Once in the salivary glands, there 
is a developmental change to the metacyclic form. This is the form that will be 
passed to the mammalian host, thus starting the lifecycle once again (Mathews, 
2005; Lee et al., 2007) (Figure 1.1). 
HOST MICROENVIRONMENTS 
  As the parasite moves through its life cycle, it will encounter an array of 
different microenvironments, including the blood, CSF, midgut, hemolymph, and 
salivary glands. Each of these microenvironments varies in its nutrient 
composition. For example, the fatty acid concentration in CSF is only 0.2% of 
that in the bloodstream. This is important because the parasite has an enormous 
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fatty acid requirement. Fatty acids are the structural components of membranes, 
signaling molecules, and most importantly, they are a part of the 
glycophosphatidylinositol (GPI) anchors, which are important for anchoring 
surface molecules involved in immune evasion and nutrient acquisition. Variant 
surface glycoproteins (VSGs) are among the GPI anchored proteins on the 
surface of T. brucei. VSG molecules mediate antigenic variation, which is the 
major immune evasion tactic employed by T. brucei. Each GPI anchor, which 
number more than 107 (covering the entire surface of the parasite), is 
myristoylated; two myristates are connected to each GPI anchor. Myristate is a 
relatively scarce fatty acid in the bloodstream (Paul et al., 2001; Vigueira and 
Paul, 2011). Since fatty acids are in such high demand and the parasite persists 
in environments that are nearly devoid of fatty acids, the parasite can 
compensate for this lack of host fatty acids by synthesizing fatty acids de novo. 
Understanding the interplay between fatty acid synthesis and fatty acid uptake 
will be important to determine how the parasite meets its fatty acid requirements 
in challenging environments. There is nothing known about the relative 
importance of fatty acid synthesis versus fatty acid uptake in vivo.   
FATTY ACID SYNTHESIS  
 Fatty acid synthesis (FAS) is a cyclical process involving four enzymatic 
reactions that extend an acyl chain by two carbons with each successive turn of 
the cycle. The first reaction is a condensation reaction of the acyl chain with a 
malonyl group, the two carbon donor molecule, a reaction catalyzed by a 
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ketoacyl synthase. The resulting ketoacyl intermediate is reduced by a ketoacyl 
reductase, dehydrated by a dehydratase, and finally reduced by enoyl reductase, 
to yield a product fatty acyl chain that is two carbons longer (Lee et al., 2007) 
(Fig. 1.2). FAS pathways implement the same four basic reactions; however, 
there are different FAS pathways that differ on many other levels.  
 There are two basic types of FAS pathways: eukaryotic type I and 
prokaryotic-origin type II. The eukaryotic type I FAS utilizes one or two very large 
multifunctional proteins, whereas the prokaryotic-origin type II FAS implements 
four distinct proteins, with discrete enzymatic functions (Schweizer and Hofmann, 
2004; Smith et al., 2003). There are many eukaryotic organisms that possess 
both type I and type II FAS pathways. Generally, the type II FAS pathway is 
localized to organelles that are prokaryotic in origin, i.e. the mitochondria, 
apicoplasts, and chloroplasts (Goodman et al., 2007; Lee et al., 2007; Stephens 
et al., 2007). Additionally, some eukaryotic organisms utilize a microsomal 
elongase (ELO) pathway, complementing their FAS machinery. ELO pathways 
utilize the same cycle of enzymatic reactions that type I and type II FAS 
pathways share, but typically only extend long chain fatty acids (16 to 18 
carbons) to very long chain fatty acids (greater than 20 carbons in length) (Toke 
et al., 1996; Oh et al., 1997; Moon et al., 2001; Jackobson, 2006). ELO pathways 
also differ in other characteristics: they are associated with organellar 
membranes and utilize coenzyme-A (CoA) rather than an acyl carrier protein as 
the carrier molecule for acyl intermediates. 
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T. brucei Fatty Acid Synthesis 
 When the T. brucei genome was completed, it was clear that T. brucei 
lacks a eukaryotic type I FAS pathway (Berriman et al., 2005). Instead, T. brucei 
possesses a cytosolic ELO pathway and a type II mitochondrial FAS pathway. 
The ELO pathway accounts for the majority (~90%) of de novo fatty acid 
synthesis in the parasite (Lee et al., 2006). There are four ELO genes, which 
encode the ketoacyl-CoA synthases of the ELO pathway. They have specific but 
overlapping chain lengths: ELO1 (C4:0-C10:0), ELO2 (C10:0-C14:0), ELO3 
(C14:0-C18:0), and ELO4, which is specific for unsaturated long chain fatty 
acids. The individual ELOs are not essential in vivo due to the overlap in 
substrate ranges. However, it was determined that T. brucei exhibits an 
environmentally dependent and stage specific requirement for its ELO pathway. 
A conditional knockout of enoyl-CoA reductase (EnCR), an enzyme downstream 
of all of the ELOs, caused a growth phenotype only when PFs were grown in low 
lipid media (Lee et al., 2006). However, in BFs, EnCR was essential for growth in 
normal media and in vivo (Soo Hee Lee, personal communication). This 
suggests that the ELO pathway, as a whole, is essential in T. brucei.  
 The ELO pathway provides an efficient mechanism of FAS in T. brucei. 
The parasite is able to modulate specific ELOs to preferentially produce specific 
chain length fatty acids, allowing T. brucei the flexibility to reside in many 
different environmental conditions and meet its demands for fatty acids (Lee et 
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al., 2007). Further, the need for a dedicated FAS pathway and subsequent 
elongation pathway is eliminated, since the ELO pathway serves both purposes.  
 In addition to its ELO pathway, the parasite does possess a mitochondrial 
type II FAS pathway. It is responsible for ~10% of the total fatty acids produced in 
the parasite and its primary products are C8:0 and C16:0. C8:0 is a precursor for 
lipoic acid, which is an important prosthetic group for many mitochondrial 
enzymes (Lee et al., 2007; Stephens et al., 2007). The mitochondrial pathway is 
also essential for parasite growth. In both PFs and BFs, reduction of the acyl 
carrier protein (ACP) by RNAi or conditional knockout resulted in reduced 
mitochondrial FAS and slowed parasite growth in culture (Stephens et al., 2007).  
 Acetyl-CoA Carboxylase 
 Acetyl-CoA carboxylase (ACC) catalyzes the first committed step of fatty 
acid synthesis: the conversion of acetyl-CoA to malonyl-CoA, the two-carbon 
donor (Barber et al., 2005). ACC is part of the biotin carboxylase family, which 
possesses a biotin prosthetic group that transfers CO2 groups from bicarbonate 
to their acceptors (e.g. acetyl-CoA).  
 T. brucei ACC (TbACC) was recently characterized and was found to be 
similar to the ACCs found in other eukaryotes, but it contains a truncated N-
terminus (Vigueira and Paul, 2011). The truncated N-terminus lacks the 
conserved serine residue found in human ACC1 and ACC2. This serine is the 
site of post-translational regulation by AMP-activated protein kinase (AMPK) 
(Barber et al., 2005).  
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 TbACC is localized to the cytosol in distinct puncta. The punctate pattern 
did not localize to other punctate organelles known in T. brucei, i.e. lipid droplets 
and glycosomes. TbACC is required for fatty acid elongation, and RNAi of 
TbACC reduced ELO activity. ACC is dispensable for growth in normal media for 
both BFs and PFs. In contrast, when PFs were grown in media containing ~20% 
of the serum lipids compared to normal media, there was a significant reduction 
in growth of the parasites. This reduction can be surmounted by the addition of 
fatty acids to the media. BFs grown in low lipid media showed no effect. 
However, it was determined that ACC is required for full virulence in a mouse 
model. When ACC-RNAi was induced in vivo, the mouse lived ~11 days longer 
than mice infected non-uninduced ACC parasites (Vigueira and Paul, 2011). 
 In Chapters 2 and 3, I explore two possible explanations as to why ACC is 
dispensable in culture but required in vivo. Chapter 2 examines ACC’s role in 
immune evasion, specifically the upregulation of endocytosis to clear surface 
immunomodulatory molecules, while Chapter 3 examines ACC’s role in host 
adaption, specifically the conservation and maintenance of internal lipid stores in 
media containing differential lipid content. These studies significantly broaden our 
understanding of ACC and serve to connect FAS to immune evasion and nutrient 
storage.  
T. brucei IMMUNE EVASION 
 T. brucei is famous for its ability to evade the mammalian immune system 
via antigenic variation. BFs are covered in a dense coat of 107 identical variant 
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surface glycoproteins (VSGs). T. brucei is able to mediate VSG switching within 
the parasite population by a hierarchal regime of expression of more than 1600 
different VSG genes (Barry and McCollogh, 2001; Donelson, 2003; Pays et al., 
2004; Pays, 2006). Before the parasite is transmitted to the mammalian host, the 
metacyclic form found in the insect salivary glands is primed for antigenic 
variation. It displays a metacyclic specific protein coat, metacyclic variant antigen 
type 4 (MVAT). The parasite then switches to a VSG coat upon transmittance 
into the mammalian host. The parasites will continue to switch their VSG coats 
throughout the course of infection, until host death (Field and Carrington, 2009). 
 VSGs cover almost the entire surface of the parasite (~95%), except for a 
small area known as the flagellar pocket (~5%). VSGs are embedded into the 
membrane via a GPI anchor. The VSG-GPI anchor is myristoylated. Myristate is 
a scarce fatty acid in the mammalian host bloodstream, and ~2X107 myristates 
are needed for the VSG coat. This creates an astounding need for fatty acids 
(especially myristate) and likely a reliance on FAS in addition to uptake (Paul and 
Vigueira, 2011).  
 T. brucei also employs a second immune evasion tactic: the upregulation 
of endocytosis to clear surface immunomodulatory molecules. Endocytosis rates 
are extremely high in BFs, ~10fold higher than PFs (Natesan et al., 2007). The 
general upregulation of endocytosis is believed to be involved in the evasion of 
the innate immune system (Field and Carrington, 2009). Upregulation of fluid 
phase and receptor-mediated endocytosis effectively clears surface bound 
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antibodies and complement (Barry, 1979; Ferrante and Allison, 1983; Pal, et al., 
2003; Engstler et al., 2007). Fluid phase endocytosis can only occur at the 
flagellar pocket (Overath and Engstler, 2004). Despite this restricted space, T. 
brucei achieves enormously high membrane turnover rates: i.e. complete VSG 
turnover occurs in ~12 minutes (Engstler et al., 2004).   
 In T. brucei, fluid phase endocytosis occurs at the flagellar pocket and 
begins with an invagination of the membrane. The fluid cargo is directed to an 
early endosome, which becomes a more acidic late endosome. The late 
endosome fuses with a lysosome, where cargo is either degraded or further 
transported within the cell (Field and Carrington, 2009).  
 Receptor-mediated endocytosis occurs when a receptor such as the 
transferrin receptor binds transferrin. The receptor and ligand are then engulfed 
into a short term endocytic compartment, known as a recycling endosome. The 
recycling endosome sorts out the transferrin necessary for iron acquisition and 
quickly recycles the GPI-anchored transferrin receptor back to the surface to 
restart the entire process. T. bucei uses a similar pathway to clear antibodies and 
complement from its surface via VSG recycling. VSG is pulled into the flagellar 
pocket with its bound antibodies/complement, engulfed into a VSG recycling 
endosome where proteases selectively degrade the antibodies, and the unbound 
VSG is recycled back to the surface (Kabiri and Steverding, 2000; Chung et al., 
2004; Chung et. al., 2008; Field and Carrington, 2009).  
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 In Chapter 2, I determine the role of ACC and FAS in both fluid phase and 
receptor-mediated endocytic pathways. I also look at the clearance of surface 
immune molecules. First, I examined the efficiency at which ACC-RNAi mutants 
can clear surface bound antibodies; then, I determined the efficiency in which 
they are able to avoid complement mediated lysis. These studies have extended 
our knowledge about the interconnection between ACC/FAS, endocytosis, and 
immune evasion.  
EXTRACELLULAR LIPID UPTAKE 
 Lipid uptake has been extensively studied in the mammalian system and 
varies greatly dependent upon specific tissue and/or cell type. In this section, I 
will summarize the primary lipid acquisition mechanisms. 
 Endocytosis of lipoproteins is one of the primary routes of lipid uptake. 
Lipoproteins consist of a polar surface mono-layer, containing phospholipids, 
apolipoproteins, and cholesterol, and a non-polar inner core, containing 
triglycerides and cholesterol esters (Wasan et al., 2008). Once endocytosed, the 
lipoprotein is transported to the lysosome, where the components are liberated. 
Additionally, specific phospholipids can be acquired from donor lipoprotein 
particles and inserted directly into the membrane (Engelmann et al., 2010).  
 Fatty acid uptake is a second major mechanism of lipid acquisition. Fatty 
acids have very low aqueous solubility and are therefore usually associated with 
membranes or proteins. This is typically albumin in the mammalian bloodstream. 
Fatty acids must first dissociate from albumin and partition into the outer leaflet of 
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the phospholipid bilayer to become internalized. Next, a “flip-flop” must occur, 
where the orientation of the fatty acid head group flips from the outer to the inner 
lipid-water interface.  Once this occurs, the fatty acid can be bound, activated, or 
incorporated into more complex lipid species (Glatz et al., 2010).  
 Fatty acid uptake can occur by protein-mediated active transport and by 
passive diffusion (Glatz et al., 2010). Fatty acid transport protein 1 (FATP1) is 
localized to the cellular membrane and actively moves fatty acids into the cell. 
Other proteins are involved in fatty acid uptake by facilitating diffusion. CD36 and 
the peripheral membrane fatty acid binding protein function in this manner, 
binding fatty acids and concentrating them on the membrane surface. The bound 
fatty acids are more easily partitioned into the membrane than albumin-
associated fatty acids; therefore, uptake rates are greatly increased.  
 Lipid rafts may play a role in fatty acid uptake as well. Caveolin exhibits 
high-affinity fatty acid binding. Its main role is to provide a plasma membrane 
docking site for CD36, which is predominantly localized to caveolae, but is 
dispersed throughout the plasma membrane when lipid rafts are disrupted by 
cholesterol depletion. There is a decrease in fatty acid uptake when CD36 is 
mislocalized (Ehehalt et al., 2006; Glatz et al., 2010). 
 Other proteins that are not associated with the plasma membrane may 
also play a role in fatty acid uptake. Fatty acids must first be activated before 
they can be broken down for energy or incorporated into a more complex lipid 
species. The activation process involves esterification to CoA by a family of 
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enzymes called acyl-CoA synthetases (ACS). Internalized fatty acids can leave 
the cell through diffusion if this activation process does not occur. Once esterified 
to the CoA, the resulting acyl-CoA is membrane impermeant. Thus, ACS 
increases the retention of fatty acids brought in by either passive diffusion or 
protein-mediated active transport (Milger et al., 2006).  
Lipid Uptake in T. brucei 
 There are a few mechanisms of lipid acquisition that have been described 
in T. brucei. First, BFs can uptake both low and high density lipoproteins via 
endocytosis (Coppens et al., 1995; Green et al., 2003). They also possess a 
lipoprotein scavenger receptor that compliments this process (Green et al., 2003; 
Thomson et al., 2009). PFs uptake lipophorin from the tse tse hemolymph, 
presumably via a similar mechanism to BF lipoprotein uptake. The uptake of 
lipophorin has been demonstrated in the related parasite, T. rangeli (Folly et al., 
2003) and a malarial parasite, Plasmodium gallinaceum (Atella et al., 2009). 
Additionally, T. brucei has a specialized mechanism for the acquisition of 
phospholipids involving the coordinated activity of three proteins; this mechanism 
was validated in vitro for the uptake of lysophosphatidylcholine (Bowes et al., 
1993). 
 There is little known about fatty acid uptake in T. brucei. None of the 
proteins involved specifically in uptake have been identified or characterized. 
There is evidence that T. brucei may employ the same two general mechanisms 
that are found in human cells, i.e. protein-mediated active transport and passive 
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diffusion. There are five ACSs in the genome and some early characterization 
has been completed for them (Jiang et al., 2000; Jiang et al., 2001; Jiang et al., 
2004). In this thesis, I delve lightly into fatty acid uptake, utilizing both 
fluorescently labeled and unlabeled fatty acids. While I did not attempt to 
characterize proteins or methods of uptake, I did elucidate the downstream 
pathway, i.e. where fatty acids go after their entrance into the cell in Chapter 3.  
LIPID DROPLETS 
 Lipid droplets are highly dynamic lipid storage organelles found mainly in 
eukaryotic organisms and some prokaryotes. Lipid droplets are usually 
composed of neutral lipids. Triacylglycerols and cholesterol esters are the major 
storage lipid, though diacylglycerols and fatty acids have also been identified 
within the organelles (Goodman, 2009; Reue, 2011). Surrounding the neutral 
lipid storage core, there is a phospholipid monolayer, with similar composition to 
the membrane found in the ER, with the acyl chains facing inward. Proteins 
involved in membrane trafficking, such as the Rab family and Arf-1 localize to the 
lipid droplet surface and are believed to play direct roles in the cells’ endocytic 
and exocytic processes (Fig. 3)(Goodman, 2009). Additionally, there is proteomic 
data localizing peroxisomal, mitochondrial, and ER-specific proteins to the 
surface of lipid droplets, increasing the evidence that these organelles are 
integrally involved in trafficking between organelles (Goodman, 2008). Aside from 
trafficking, lipid droplets function in energy storage, lipid metabolism, and 
protection against the toxic effects of non-esterified sterols, lipids, and 
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exogenous non-polar compounds. However, the extent of involvement in each of 
these roles is highly variable depending upon species, cell, and tissue type 
(Flaspohler et al., 2010). 
 Lipid droplets are dynamic organelles. They are able to self-associate and 
associate with other organelles, such as endosomes and ER. The regulation of 
lipid droplet size and number is largely undefined. It is known that certain 
environmental conditions can influence both size and number, e.g. an increase in 
extracellular lipid content results in an increase in lipid droplet number and/or 
size (Reue, 2011; Flaspohler et al., 2010). Additionally, it is not known exactly 
how lipid droplets form. There are two main hypotheses on lipid droplet 
formation. The first hypothesis claims that lipid droplets form as buds from the 
ER, an idea supported by proteomic data that determined that the same proteins 
found on the surface of lipid droplets are found on the surface of the ER 
(Goodman, 2008). Also, 96% of lipid droplets were scored as associating with ER 
in yeast (Goodman, 2009). Lastly, there is some evidence in yeast that lipid 
droplets may not leave the ER. Instead of becoming independent organelles, 
they remain associated with the ER and could be considered specialized parts of 
the ER (Goodman, 2008). 
 The alternative hypothesis of lipid droplet formation centers around the 
idea that lipid droplets are not buds of the ER. Rather, they are simple organelles 
that are manufactured separately from the ER and are able to associate with 
many organelles within the cell as needed. This hypothesis garners support 
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because lipid droplets do not just associate exclusively with the ER but associate 
with many different organelles within the cell. For example, within a muscle cell, 
the lipid droplets also associate with mitochondria, and it is believed that this 
association enhances energy production by coupling the release of fatty acids 
with their beta oxidation (Goodman, 2009). Lipid droplets are also known to 
associate with peroxisomes in both animals and plants (Goodman, 2008; 
Goodman, 2009). In plants, lipid droplets supply the phospholipid membranes of 
glyoxysomes. In animal cells, lipid droplets interact with peroxisomes via what is 
believed to be bidirectional lipid movement between organelles, because the lipid 
droplet core is rich with ether lipids that are synthesized within the peroxisomes. 
Lastly, lipid droplets associate with endosomes (Goodman, 2009). High 
exogenous concentrations of cholesterol and fatty acids increase caveolin on the 
surface of lipid droplets and a decrease their appearance on the ER, suggesting 
that uptake into endosomes will directly traffic these lipids to lipid droplets, 
bypassing the ER (Goodman, 2008; Goodman, 2009). 
Lipid Droplets in T. brucei 
 Lipid droplet synthesis and characterization in T. brucei is a largely 
unexplored area of research. It is unknown how lipid droplets are synthesized 
and trafficked within the parasite. Additionally, the proteins that are involved in 
these processes or colocalize to the surface of lipid droplets are mostly unknown. 
Recently, one kinase, Lipid Droplet Kinase (LDK), was found to localize to the 
surface of lipid droplets in T. brucei. LDK is on or embedded within the 
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phospholipid monolayer of lipid droplets and is involved in both the synthesis and 
maintenance of lipid droplets (Flaspohler, et al., 2010). When LDK was knocked 
down by RNAi, lipid droplet number decreased. Further, when uninduced cells 
were exposed to low lipid media for 24 hours, there was an increase in lipid 
droplet formation, presumably due to the upregulation of fatty acid synthesis. 
However, LDK-RNAi cells did not experience an increase in lipid droplet number 
when subjected to the same treatment, indicating a role in both lipid droplet 
synthesis and maintenance in T. brucei (Flaspohler, et al., 2010).  
 In Chapter 3, I characterized T. brucei lipid droplet maintenance and 
synthesis further. I examined the effects of exogenous lipid content on lipid 
droplet number and maintenance. I then looked at the role of fatty acid synthesis, 
specifically through the knockdown of ACC by RNAi, on lipid droplet number and 
maintenance. Lastly, I determined the effects of both ACC-RNAi and the 
environmental status of lipids on bulk neutral lipid content in T. brucei. My studies 
represent an initial characterization of lipid droplet biology in T. brucei.   
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FIGURES 
Figure 1.1: T. brucei life cycle. T. brucei alternates between its insect host, the  
tse tse fly, and its mammalian hosts. Figure adapted from Lee S. H., Stephens J. 
L., and Englund P. T. (2007) A fatty-acid synthesis mechanism specialized for 
parasitism. My research focuses on the Procyclic form (PF) and “Long, slender” 
form (BF) Nat Rev Microbiol 5: 287-297. 
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Figure 1.2: Enzymatic reactions of the fatty acid synthesis elongase 
pathway by T. brucei. The cycle consists of four enzymatic reations. Each turn 
of the cycle yields an acyl-CoA product that is 2 carbons longer. Figure adapted 
from Lee S. H., Stephens J. L., and Englund P. T. (2007) A fatty-acid synthesis 
mechanism specialized for parasitism. Nat Rev Microbiol 5: 287-297. 
 
 
 
 
 
 
 
20 
 
 
Figure 1.3: Lipid Droplet. Lipid droplets are surrounded by a phospholipid 
monolayer and contain a neutral lipid storage core. Figure adapted from Krahmer 
N., Guo, Y., Farese, R., and Walther, T. (2009) Snapshot: Lipid Droplets. Cell 
139:5,1034.  
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ABSTRACT 
 Trypanosoma brucei, the causative agent of human African 
trypanosomiasis, employs the upregulation of endocytosis to clear lytic cell 
surface immune complexes as an immune evasion tactic. This strategy involves 
membrane turnover, which presumably requires fatty acid synthesis (FAS) and 
may depend on environmental lipid availability. To explore the role of fatty acid 
synthesis in membrane turnover, we have examined the consequences of RNA 
interference (RNAi)-mediated reduction of acetyl-CoA carboxylase (ACC), the 
first committed step of fatty acid synthesis. First, we examined both fluid phase 
endocytosis, using a fluorescent dextran marker, and receptor-mediated 
endocytosis, using a fluorescent transferrin marker, in bloodstream form (BF) 
ACC-RNAi parasites and found a 54-88% reduction in both endocytic pathways 
in low, normal, and high lipid media. Next, we tested the effect of ACC-RNAi on 
the parasites’ ability to clear surface-bound antibodies and determined that the 
ACC-RNAi cells required more time (25-27%) to clear fluorescently conjugated 
antibodies from the surface. Lastly, we tested the effect of ACC-RNAi on 
complement mediated lysis and found that ACC-RNAi resulted in a 31-45% 
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reduction in the ability to avoid complement-mediated lysis. Therefore, T. brucei 
relies on ACC to maintain high levels of endocytosis, clear immune complexes, 
and avoid complement mediated lysis, suggesting that ongoing fatty acid 
synthesis is required for immune evasion in the mammalian host 
INTRODUCTION 
 Trypanosoma brucei, the causative agent of human African 
trypanosomiasis (HAT) and nagana in livestock, is a protozoan parasite vectored 
by the tse tse fly that infects both humans and livestock. Over the course of 
infection, the parasite encounters a diverse array of microenvironments, including 
the bloodstream and cerebrospinal fluid, which differ in nutrient content. Notably, 
there is a ~300X lower concentration of lipids in the cerebrospinal fluid compared 
to the bloodstream (Lentner, 1981). T. brucei has an obligate fatty acid 
requirement because they are important constituents of the 
glycosylphosphatidylinositol (GPI) anchors, which anchor cell surface 
glycoproteins. Bloodstream form (BF) T. brucei is covered with 1 x 107 GPI-
anchored variant surface glycoproteins (VSGs), each requiring two myristates 
(Paul et al., 2001). To meet this requirement, the parasite is able to acquire fatty 
acids in two ways: de novo synthesis of fatty acids or uptake of fatty acids from 
the host (Smith and Bütikofer, 2010). Fatty acid uptake requires less energy than 
synthesis. However, because the abundance in some environments is very low 
(i.e. the cerebrospinal fluid) the parasite is unable to rely solely on uptake to 
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satisfy its need. Therefore, de novo synthesis is utilized to meet the parasite’s 
fatty acid requirement. 
 Two fatty acid synthesis pathways have been described in T. brucei. The 
fatty acid elongase (ELO) pathway of the endoplasmic reticulum serves as the 
major pathway for synthesis, accounting for ~90% of fatty acids synthesized (Lee 
et al., 2006). The second pathway is found in the mitochondrion and accounts for 
~10% of the fatty acids synthesized (Stephens et al., 2007; Guler et al., 2008). 
Both pathways are essential (Lee et al., 2006; Stephens et al., 2007). The ELO 
pathway is initiated by the conversion of acetyl-CoA to malonyl-CoA via acetyl-
CoA carboxylase (ACC). This is considered the first committed step of fatty acid 
synthesis (Tehlivets et al., 2007; Saggerson, 2008). Previously RNA interference 
(RNAi) of T. brucei ACC, demonstrated that in BFs, TbACC was not required for 
growth in culture but was necessary for full virulence in mice (Vigueira and Paul, 
2011). One major difference between growth in culture and growth in mice is the 
presence of the host immune system. Thus, we propose that ACC is required in 
T. brucei for immune evasion. 
 The major immune evasion tactic of T. brucei is antigenic variation. The 
BF parasite is covered in a dense coat of 107 VSGs and is able to mediate coat 
switching within the population following a hierarchal regime of expression of 
~1000 different VSG genes (Barry and McCulloch, 2001; Donelson, 2003; Pays 
et al., 2004; Pays, 2006). The parasite switches from an initial coat, metacyclic 
variant antigen type 4, expressed in the metacyclic stage in the salivary glands, 
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to a single VSG, which continues to switch throughout the course of infection 
until the death of the host (Field and Carrington, 2009).  
 A second immune evasion tactic mechanism involves the upregulation of 
endocytosis. Endocytosis rates in BFs are ~10 fold higher than those of the 
insect procyclic form (PF) parasites (Natesan, et al., 2007). Upregulation of fluid 
phase endocytosis and receptor mediated endocytosis can effectively clear 
antibodies and serum complement bound to the parasite surface (Balber et al., 
1979; Ferrante and Allison, 1983; Donelson, et al., 1998). It is believed that this 
upregulation is one of the early tactics used to evade the innate immune system 
(Field and Carrington, 2009). Endocytosis occurs at the flagellar pocket, which 
accounts for only ~5% of the entire membrane (Morgan et al., 2002a,b; Overath 
and Engstler, 2004). Antibody clearance is achieved by the internalization of 
VSGs through the flagellar pocket into a recycling endocytic pathway, where the 
VSG-antibody complex is sorted, with the antibody being degraded and released 
outside the cell and the VSG recycled back to the surface (Donelson et al., 2009; 
Field and Carrington, 2009). The avoidance of complement-mediated lysis is also 
attributed, in part, to the upregulation of endocytosis. When antibodies bind the 
surface of T. brucei, complement is recruited to lyse the cells (Balber et al., 1979; 
Russo et al., 1993, Donelson et al., 1998; O’Beirne et al., 1998; Engstler et al., 
2007; Natesan et al., 2007). Likely, T. brucei is able to evade this mechanism by 
internalizing antibody-bound VSGs and recycling unbound VSGs back to the 
surface.  
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 Here, we hypothesize that ACC is required for full virulence in mice 
because fatty acid synthesis is important in maintaining elevated endocytosis 
levels. Because T. brucei encounters microenvironments differing in lipid content 
and possesses the ability to synthesize fatty acids de novo and take up host fatty 
acids, we explore the requirement for ACC in the upregulation of endocytosis and 
the clearance of surface-bound antibody and complement. We show that ACC-
RNAi reduces both fluid phase and receptor-mediated endocytosis. We also 
determine that ACC-RNAi reduces the parasite’s ability to clear surface-bound 
antibodies. Finally, we demonstrate that ACC is necessary to avoid complement-
mediated lysis. 
RESULTS 
ACC-RNAi reduces fluid phase and receptor-mediated endocytosis 
 As shown previously, while ACC-RNAi did not affect the growth of 
T. brucei in vitro, it did affect the virulence of T. brucei within the mouse (Vigueira 
and Paul, 2011). To investigate this decrease in virulence, we decided to 
investigate one of the parasite’s immune evasion tactics, increased endocytosis. 
BF parasites exhibit a very high rate of endocytosis, which is proposed to help 
BFs evade the immune system (Field and Carrington, 2009). Because this 
increase in endocytosis is related to host adaption and immune evasion (Engstler 
and Overath, 2004; Field and Carrington, 2009), we assessed the parasites’ 
ability to undergo both fluid-phase and receptor mediated endocytosis in BF 
ACC-RNAi cells. Further, because the parasite can encounter both low and high 
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lipid conditions in the host, we assessed the effect of ACC-RNAi on these 
processes under three different lipid conditions: “normal” lipid (12% serum, which 
corresponds to the standard culture media), “low” lipid (4% serum), and “high” 
lipid (22% serum). 
 ACC-RNAi effectively reduces detectable ACC protein levels in BFs (96% 
compared to uninduced cells) (Fig. 2.1A), under all serum lipid levels tested. This 
reduction has no impact on the doubling time, even when grown in low lipid 
medium (Fig. 2.1B). After 9 days of ACC-RNAi induction, endocytosis of FITC-
dextran was reduced by 88 ± 8% when T. brucei was grown in normal lipid media 
(Fig. 2.2B). ACC-RNAi induction (9 days) also reduced the amount of FITC-
dextran endocytosed by T. brucei by 54 ± 22% in low lipid media (Fig. 2.2C) and 
55 ± 23% in high lipid media (Fig. 2.2D). Additionally, when cells were grown in 
low lipid media for 3 or more days, there was a 3-4 fold reduction in fluid-phase 
endocytosis compared to normal and high lipid media, regardless of ACC-RNAi 
induction (Fig. 2.2B-D).  
 Next, we assessed the effect of ACC-RNAi on transferrin receptor-
mediated endocytosis, because its endocytic pathway is similar to the VSG 
recycling pathway (Steverding, et al., 1995; Overath and Engstler, 2004; 
Subramanya et al., 2009). After 9 days of induction, ACC-RNAi decreased 
endocytosis of Alexa Fluor-conjugated transferrin by 87 ± 14% in normal lipid 
media (Fig. 2.3B), 73 ± 19% in low lipid media (Fig. 2.3C), and 61 ± 8% in high 
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lipid media (Fig. 2.3D). Unlike for FITC-dextran uptake, we observed no effect of 
media serum lipids on transferrin receptor-mediated endocytosis. 
ACC-RNAi reduces clearance of surface-bound antibodies 
 Previously, it was demonstrated that the increased endocytosis rates in 
BFs serves as a mechanism to clear surface antibody complexes (Steverding, et 
al., 1995; Overath and Engstler, 2004; Field and Carrington, 2009). This 
clearance process is believed to aid the parasites’ survival during early stages of 
infection (Field and Carrington, 2009). Since we found a decrease in both fluid 
phase and receptor mediated endocytosis upon ACC-RNAi, we assessed the 
ability of T. brucei to clear surface-bound antibody complexes using a previously 
published assay (Pal et al., 2003). First, we isolated a population of BF ACC-
RNAi cells expressing the 221 VSG variant by fluorescence-activated cell sorting. 
We then incubated these 221 VSG-expressing cells with a polyclonal anti-221 
VSG antibody and tracked its endocyosis and subsequent recycling to the 
surface via a fluorescently-labeled secondary antibody. Silencing ACC for 9 days 
led to an increase in the time it took for the parasites to endocytose and recycle 
their VSG back to the surface (Fig. 2.4A-D; Table 1). The increase in recycling 
time (∆t) was similar in all lipid conditions, with a 25 ± 8%, 26 ± 8%, and 27 ± 9% 
reduction in low, normal, and high lipid media, respectively (Fig. 2.4; Table 1). 
ACC-RNAi reduces the avoidance of complement-mediated lysis 
 T. brucei also avoids complement-mediated lysis (Balber et al., 1979; 
Donelson et al., 1998) through the endocytosis and degradation of surface bound 
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VSG-antibodies. Because BF ACC-RNAi parasites have a defect in endocytosis 
and the ability to clear surface bound antibodies, we explored whether ACC-
deficient parasites were also impaired in their ability to avoid complement-
mediated lysis. To do this, we incubated 221 VSG-expressing BF ACC-RNAi 
cells with anti-221 VSG polyclonal antibody and guinea pig complement and 
monitored cell viability using the Cell Titer Blue assay. Induction of ACC-RNAi for 
9 days resulted in a 31-45% increase cell sensitivity to complement-mediated 
lysis in all three lipid medias (Fig. 2.5). Lysis was confirmed microscopically 
(Data not shown). 
DISCUSSION 
 Previously, it was demonstrated that ACC was necessary for full virulence 
in the mouse model (Vigueira and Paul, 2011). Here, we investigate the role of 
fatty acid synthesis by ACC-RNAi in one of the major immune evasion 
mechanisms employed by T. brucei, the upregulation of endocytosis to clear 
surface immune complexes and to avoid complement mediated lysis. We 
demonstrate that there is a reduction in both fluid phase and receptor-mediated 
endocytosis in ACC-RNAi parasites. Further, this reduction in endocytic activity 
increases the kinetics of VSG-antibody complex clearance from the surface of 
ACC-RNAi BFs. Lastly, because antibodies are not cleared as quickly from the 
surface of ACC-RNAi parasites, they are more sensitive to complement-mediated 
lysis.  
34 
 
 The reduction in both fluid phase and receptor-mediated endocytosis is 
believed to be due to the parasite’s inability to undergo membrane turnover. As 
membrane is depleted by endocytic processes, the parasite cannot maintain the 
high levels of membrane turnover necessary to continue the high rates of 
endocytosis. Since fatty acids are constituents of membrane lipids, the depletion 
of fatty acids must affect the parasite’s ability to synthesize additional membrane 
lipids. Therefore, the decrease in both fluid phase and receptor-mediated 
endocytosis can be attributed to a downstream effect of the loss of fatty acid 
synthesis, which in turn results in a lack of the basic building blocks of plasma 
membrane lipids. Additionally, lipids play a role in secondary signaling in 
endocytic pathways. For example, diacylglycerol is a secondary signaling 
molecule released from phospholipids by phospholipase C (Davis et al., 1985). 
Together, the inability to replenish the membrane and signaling lipids could 
provide an explanation as to why ACC-RNAi negatively affects endocytosis.  
 One interesting finding is that there was a 3-4 fold reduction in the fluid 
phase endocytic pathway, regardless of induction state, in parasites grown in low 
lipid medium for 3 or more days. However, this general reduction in endocytic 
capabilities was not observed in the same parasites when assaying for receptor 
mediated endocytosis. The dichotomy between the effect of ACC-RNAi on these 
two pathways cannot be attributed to vesicle formation, i.e. fluid phase vesicles 
are not formed as readily as receptor-mediated. Vesicle formation is the same for 
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both endocytic processes in T. brucei (unlike in mammalian cells). To date, only 
clathrin coated vesicles have been described in T. brucei (Allen et al., 2003).  
 We could also surmise that fluid phase endocytosis is somehow a more 
membrane intensive activity than receptor-mediated endocytosis; however, this is 
unlikely. Both processes occur at the same location and utilize very similar 
machinery, i.e. clathrin coated vesicles and Rab family proteins (Jeffries et al., 
2001; Denny et al., 2001; Pal et al., 2002; Pal et al., 2003; Grunfelder et al., 
2003.) 
 It may be interesting to explore this finding further by growing parasites in 
low lipid medium for time points shorter than 3 days, where there may be a vast 
increase in endocytosis, similar to what was observed in yeast (Conner and 
Schmid, 2003). If there is a large increase in fluid phase but not receptor-
mediated endocytosis, perhaps the parasite begins to down regulate fluid phase 
endocytosis to preserve membrane for essential processes such as receptor-
mediated endocytosis of transferrin for iron acquisition.  
 In addition to effects on endocytosis, ACC-RNAi also reduced the 
clearance of antibody complexes from the parasite surface. It is important to note 
that this was attributed to endocytosis and not to migration of VSG to the flagellar 
pocket nor exocytosis of VSG and antibody back to the surface. When examining 
the kinetic curves, there is an obvious delay in endocytosis but not in exocytosis 
back to the surface. This delay could be due to a defect in the migration of VSG 
to the flagellar pocket or to defects in the VSG recycling pathway. Antibody-
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bound VSGs migrate to the flagellar pocket via hydrodynamic flow, with the 
antibodies bound to the VSGs acting like “sails” driven by parasite movement 
(Engstler et al., 2007). We observed no defects in parasite movement upon 
microscopic examination, which argues against a defect in the hydrodynamic 
flow of VSGs toward the flagellar pocket. However, as problems in membrane 
composition could reduce the efficency of the VSG flow without a noticeable 
change in parasite movement; we further examined antibody-bound VSG 
migration by microscopy and observed “capping” near the flagellar pocket. This 
supports our conclusion that the migration remains unaffected, while there is a 
delay in the endocytosis of the antibody-bound VSGs from the surface. Further, 
the recycling endocytosis pathway of VSG is similar to that of GPI anchored 
transferrin receptor (O’Beirne et al., 1998; Field and Carrington, 2009), which we 
showed was defective under ACC-RNAi conditions. Therefore, we attribute the 
observed defect in antibody clearance upon ACC-RNAi to a defect in endocytosis 
rather than in the hydrodynamic flow of VSGs to the flagellar pocket.
 Because we demonstrated that ACC-RNAi resulted in a reduction in 
endocytosis to clear surface bound antibodies, we examined susceptibility to 
complement-mediated lysis and found that the ACC-RNAi parasites were more 
sensitive. The increased susceptibility to complement-mediated could be due to 
decreased endocytosis of surface-bound antibodies. The sensitivity of the ACC-
RNAi parasites to complement remained low, even when antibody accumulation 
of the surface was high. There may be an alternative mechanism involved in the 
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avoidance of complement-mediated lysis. In Leishmania spp., a closely related 
trypanosomatid, GP63 is a surface bound protease that aids in its ability to infect 
cells and avoid complement-mediated lysis by cleaving the complement 
component C3b to the inactive C3bi (Chang et al., 1986; Liu et al., 1992; 
Soteriadou et al., 1992; Brittingham et al., 1995; Yao et al., 2003; Olivier and 
Hassani, 2010). Upon a genome wide search, it was determined that T. brucei 
possesses several genes that encode a similar protein and may be involved in 
the avoidance of complement-mediated lysis (Donelson et al., 1998; Yao et al., 
2003). 
 We determined a role for ACC in one immune evasion mechanism; 
however, the major immune evasion mechanism employed by T. brucei is not the 
upregulation of endocytosis, but rather, antigenic variation (Barry and McCulloch, 
2001; Donelson, 2003; Pays et al., 2004; Pays, 2006). Future studies should also 
explore the role of ACC in VSG presentation and switching. As each VSG 
molecule is GPI anchored to the membrane and each GPI anchor contains 2 
myristates (Paul et al., 2001), it is possible that fatty acid synthesis might play a 
role in both presentation of VSG and switching of VSG. This could explain ACC’s 
dispensability in vitro but necessity in vivo. We expect that ACC-RNAi parasites 
would be defective in one or both of these processes due to the high demand of 
fatty acid synthesis. 
 Our study examined the effect of ACC-RNAi and reduced fatty acid 
synthesis in very downstream processes. It is important to note that fatty acids 
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are important building blocks of most lipids utilized in the cell for membrane 
biogenesis and signaling. Other groups have examined the effects of 
phosphatidylinositol phosphate (Bussolino et al., 2001) and sphingolipid 
synthesis (Conzelmann, 2012) on lipid biogenesis and cell viability and found that 
both are necessary for lipid biogenesis. Without a source of lipids, the cell 
ultimately cannot survive. T. brucei presents an interesting problem, in that it can 
uptake and synthesize fatty acids. However, we have demonstrated that uptake 
alone cannot fulfill the parasite’s need. If both fatty acid synthesis and uptake can 
be blocked, then T. brucei would not survive. Continued study of both fatty acid 
synthesis and fatty acid uptake will be needed to determine the viability of fatty 
acid metabolism pathways as a potential drug target.  
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MATERIALS AND METHODS 
Reagents 
 All chemicals and reagents used in these studies were purchased from 
Thermo Fisher Scientific and Sigma except: Iscove’s Modified Dulbecco’s 
Medium (IMDM), Minimum Essential Media (MEM), 4’-6-diamidino-2-
phenylindole (DAPI), Fluorescein isothiocyanate- dextran (FITC-dextran), 
transferrin-Alexa Fluor 488, and secondary goat anti-rabbit IgG FITC-conjugated 
antibody were from Invitrogen; Serum Plus was fromJRH Biosciences; and 
delipidated fetal bovine serum was from Cocalico Biologicals. The AnTAT-221 
variant anti-VSG antibody was generated by Drs. David Alexander and Jay 
Bangs (Univ. of Wisconsin), and was a generous gift from Dr. James Morris 
(Clemson University).  
 Trypanosome Cell Lines and Growth Media 
 BF 90-13 ACC-RNAi cell lines have been described (Vigueira and Paul, 
2011) Normal lipid, low, and high lipid growth media were prepared using HMI-9 
medium (Hirumi and Hirumi, 1989) supplemented with 2.5 µg/ml G418, 5 µg/ml 
hygromycin, and 2.5 µg/ml phleomycin. Normal lipid media contained 10% heat-
inactivated fetal bovine serum (FBS) and 10% Serum Plus (JRH Biosciences), 
resulting in a 12% serum lipid content. Low lipid media contained 10% 
delipidated FBS (Cocalico Biologicals) and 10% Serum Plus, resulting in a 4% 
serum lipid content. High lipid media contained 20% heat-inactivated FBS and 
10% Serum Plus, resulting in a serum lipid content of 22%. ACC-RNAi was 
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induced by the addition of 1 µg/ml Tetracycline to the media and fresh Tet was 
added at the time of cell passage every two days. To isolate cells expressing the 
221 VSG variant, BF 90-13 ACC-5 lines were incubated with a 1:1000 dilution of 
anti-221VSG polyclonal antibody (Balber et al., 1979) and 1:100 dilution of 
polyclonal alexa-fluor 488 conjugated anti-rabbit polyclonal antibody and sorted 
for 221 VSG expressing cells using the Beckman Coulter MoFlo XDP cell sorter 
at the Center for Tropical and Emerging Global Diseases Flow Cytometry Center 
(University of Georgia). This isolated population was used within 15 days of 
sorting and we observed a ~5% background of switched cells by day 15 post-
sorting. 
Growth Curves and Streptavidin Blotting 
 To perform a growth analysis, cultures were back-diluted to ~1 x 104 
cells/ml in fresh media and divided into two. The Induced culture was 
supplemented with 1 µg/ml Tetracycline to induce ACC-RNAi, while the control 
uninduced culture received ethanol. The cell densities of the cultures were 
monitored every day by hemocytometer counts. Average doubling times were 
calculated from the linear part of the growth curve. 
 Hypotonic lysates were prepared as described (Morita et al., 2000). 
Streptavidin blotting can detect the biotin prosthetic group on ACC and was 
performed essentially as described (Vigueira et al., 2011). Briefly, hypotonic 
lysates were fractionated on 10% SDS-PAGE gels, transferred to nitrocellulose, 
and blocked in Wash Buffer (1% dry milk, 1X TBS, 0.05% Tween-20). The blot 
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was then cut; the top half was probed for ACC with streptavidin-horseradish 
peroxidase conjugate (SA-HRP) (1:400 in 0.2% dry milk, 1X Tris-buffered saline 
(TBS), 0.05% Tween-20); and the bottom for tubulin with a mouse anti-tubulin 
antibody (clone B-5-1-2; Sigma) diluted 1:50,000 in Wash Buffer followed by 
HRP-conjugated goat anti-mouse IgG antibody (Invitrogen) diluted 1:10,000 in 
Wash Buffer. Semi-quantitative analysis of the blots was performed using 
densitometry (NIH Image J software) of exposed films (unsaturated signal within 
the linear range of the film). 
Endocytosis Assays 
 FITC-dextran and transferrin-Alexa Fluor 488 uptake experiments were 
performed essentially as described in (Subramanya et al., 2009). BF ACC-RNAi 
uninduced and induced cells were grown in low, normal, or high lipid media for 3, 
6, or 9 days. Cells were harvested by centrifugation (1000 x g) washed once in 
BBSG (50 mM bicine-Na+ pH 8, 50 mM NaCl, 5 mM KCl, 70 mM glucose), and 
resuspended at a density of 5 x 106 cells/mL vol in serum-free HMI-9+1% bovine 
serum albumin. Cells (5 x 106) were incubated with 2 mg/mL FITC-dextran or 20 
µg/mL transferrin-Alexa Fluor 488 for 10 min at 37 °C. Cells were centrifuged 
(3000 x g for 5 min at 4oC) and then washed 5 times with ice cold BBSG+2% 
sodium azide to terminate uptake. Because FITC-dextran fluorescence is 
sensitive to the lower pH in endocytic organelles, the cells incubated with FITC-
dextran were subsequently lysed with 0.2% Triton-X-100 (final concentration) to 
release all intracellular FITC-dextran. The FITC-dextran incubated cell lysate and 
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the unlysed transferrin-Alexa Fluor 488 incubated cells were then diluted 1:2 in 
BBSG + 2% sodium azide and transferred to a 96-well plate, and cell-associated 
fluorescence was monitored (excitation 490 emission 525) using a FLX800 
fluorescence plate reader equipped with KC4 software (BioTek Instruments). 
Final fluorescence values were obtained by subtracting the “cell only” control 
from the samples incubated with the fluorescent markers. 
Microscopy 
 Microscopy was performed essentially as described (Field et al., 2004). To 
monitor endocytosis, ~1 x 107 BF ACC-RNAi induced and uninduced cells were 
harvested by centrifugation (800 x g, 10 min), incubated with either 2 mg/ml 
FITC-dextran or 20 µg/ml transferrin-Alexa Fluor 488 dissolved in serum-free 
HMI-9+1% bovine serum albumin 10 min, washed 3 times in ice-cold Voorheis’s 
modified PBS (vPBS) (Nolan et al., 2000), and fixed on ice in 3% 
paraformaldehyde (w/v) in vPBS for 10 minutes. Fixed parasites were adhered to 
poly-L-lysine treated glass slides and permeabilized for 10 min in 0.1% Triton X-
100 (v/v) in vPBS. The nucleus and kinetoplast were stained with 4’-6-diamidino-
2-phenylindole (DAPI) (1 mg/ml in vPBS). 
 For the antibody clearance studies, VSG 221 expressing ACC-5 cells 
(induced and uninduced for ACC-RNAi) were grown for 9 days in low, normal, or 
high lipid media. Cells (1 x 107) were harvested by centrifugation at 800 x g. Cells 
were washed once with ice cold vPBS and fixed on ice in 3% paraformaldehyde 
(w/v) in vPBS for 10 min. Fixed parasites were adhered to poly-L-lysine treated 
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glass slides and incubated in microscopy blocking solution (MBS: 0.5% bovine 
serum albumin (BSA) (w/v), 5% normal goat serum (v/v), 20% FBS (v/v) in vPBS) 
for 1 h. The fixed, intact cells were then incubated with 1:1000 rabbit IgG anti-
VSG 221 antibody (McDowell et al., 1998) in MBS for 30 min., washed 2X in 
MBS, then incubated with 20 µg/mL goat anti-rabbit IgG secondary FITC-
conjugated antibody (Invitrogen) in MBS for 1 h. The slide was washed 4X in 
MBS. The nucleus and kineotplast DNA were stained with DAPI as above. 
 For timed incubations of internalized antibodies, cells were harvested, 
washed, then incubated with the primary anti-VSG 221 antibody for various 
timepoints at 37oC. The cells were immediately washed, fixed in 3% 
paraformaldehyde, and permeabilized with 0.1% Triton-X-100 in vPBS (v/v) prior 
to incubation with primary and secondary antibodies and DAPI as described 
above. 
 Images were collected using a Nikon TE2000 widefield epifluorescence 
microscope and image acquisition was performed using Nikon NIS Elements 
software package. Image analysis was further performed using NIH Image J and 
Adobe Photoshop.  
Antibody clearance assay 
 Antibody clearance assays were performed essentially as described by 
(Pal, et al., 2003). BF ACC-RNAi uninduced and induced parasites expressing 
the VSG 221 surface coat were harvested at 1,000 x g and resuspended at 3 x 
106 cells/ml in 200 µL of ice cold TES buffer (120 mM NaCl, 5 mM KCl, 3 mM 
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MgSO4, 16 mM Na2HPO4, 5 mM KH2PO4, 30 mM Tris, 10 mM glucose, 0.1 mM 
adenosine, pH 7.4). The cells were then incubated at 30oC for 15 min to allow 
cycles of endocytosis and exocytosis of media derived material to be completed. 
The incubation was terminated by the addition of 4 volumes of ice cold TES. The 
cells were pelleted by centrifugation (1000 x g, 10 min. at 4oC), and resuspended 
in ice-cold TES to a density of 5 x 106 cells/mL. Cells were then incubated with 
1:1000 rabbit anti-VSG 221 IgG antibody for 30 min on ice, washed 2X in ice-
cold TES, and then incubated with 20 µg/mL of goat anti-rabbit IgG FITC-
conjugated secondary antibody for 1 hour on ice. The cells were then washed 2X 
in TES, resuspended in TES at 5 x 106 cells/mL, and transferred to a 96 well 
plate for analysis using the FLX800 fluorescence plate reader equipped with KC4 
software. Kinetic analysis was performed by measuring fluorescent signal 
(excitation 490 emission 525) continuously every 2 min for 90 min at 37oC. Final 
fluorescent values were obtained by subtracting the “cell only” control from the 
treated cells.  
Complement-mediated lysis assay 
 The complement-mediated lysis assay was carried out essentially as 
described by (Balber et al., 1979) as trypanolysis assay. VSG 221 expressing 
ACC-5 cells (induced and uninduced for ACC-RNAi) were grown for 9 days in 
low, normal, or high lipid media. Cells were harvested by centrifugation at 1000 x 
g and resuspended at 5 x 106 cells/mL in BBSG. The cells were incubated with 
1:1000 anti-VSG 221 rabbit IgG antibody in BBSG for 30 min on ice. The cells 
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were then washed 2X at 1000 x g for 5 min at 4oC. Cells with bound antibody 
were then incubated at 37oC for the time corresponding to the previously 
measured ∆t determined for each lipid media (Table 2.1) to allow clearance of 
surface-bound antibody (17 min for normal media, 18 min for low lipid media, and 
16 min for high lipid media). The cells were transferred to a 96 well plate and 
then incubated with 25% (final v/v) guinea pig complement reconstituted in BBSG 
containing 5 mM CaCl2 and 5 mM MgCl2. Cells were incubated in the presence of 
complement for 30 min. at 37oC. Cell survival was assessed by incubation of the 
cells with 0.05% (final v/v) Cell TiterBlue reagent for 60 min. Live cells can 
reduce the Cell Titer Blue dye reagent to a fluorescent product, which can be 
measured using the fluorescence plate reader (excitation 560, emission 590).   
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Figure 2.1. ACC-RNAi does not affect doubling time. A. BF ACC-RNAi cells 
grown in low, normal, and high lipid media were induced for ACC-RNAi for 3, 6, 
or 9 days. Total lysates (20 µg protein) were probed for ACC by blotting with 
streptavidin-HRP (SA-HRP), which detects the ACC biotin prosthetic group (top 
panel), and with anti-tubulin antibody as a loading control (bottom panel). B. BF 
ACC-RNAi cells were seeded into low, normal, or high lipid media, induced for 
ACC-RNAi for 7 days, cell densities of induced (+RNAi) and uninduced control 
(No RNAi) cultures were recorded daily and used to calculate doubling time. 
Average doubling times +/- standard deviation are shown (n=3).  
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Figure 2.2. Fluid phase endocytosis is reduced in BF ACC-RNAi cells after 
9 days for all growth conditions. A. BF ACC-RNAi cells were incubated with 
150 µg/ml FITC-dextran for 10 min., fixed, permeabilized, and stained with 4’,6’-
diamidino-2-phenylindole (DAPI) to show nuclear and kinetoplast DNA, as 
described (Field et al., 2004). Representative microscopic image of Phase/DAPI 
overlay (left) and FITC-dextran fluorescence (right) (uninduced, normal media) is 
shown. Scale bar = 2 µm. B-D. BF ACC-RNAicells were grown in normal, low, or 
high lipid media and induced for ACC-RNAi for 3, 6, or 9 days. Induced (+RNAi) 
and uninduced control  (No RNAi) cells were incubated with 150 µg/ml FITC-
dextran for 10 minutes at 37oC, lysed with 1% Triton-X-100, and fluorescence 
determined using a plate reader. Mean fluorescence +/- standard deviations is 
shown (n=3). Comparisons between uninduced and induced were performed 
using a 2-tailed Student’s t-test. B. Normal media (*, p=0.04). C. Low lipid media 
(*, p=0.0003). D. High lipid media (*, p=0.05).  
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Figure 2.3. Receptor mediated endocytosis is reduced in BF ACC-RNAi 
cells after 9 days for all growth conditions. A. BF ACC-RNAi cells were 
incubated with 20 µg/ml of transferrin-Alexa Fluor 488 for 10 minutes, fixed, 
permeabilized, and stained with DAPI as in Fig. 2A. Representative microscopic 
image of Phase/DAPI overlay (left) and Transferrin-Alexa 488 fluorescence 
(right) (uninduced, normal media) is shown. Scale bar = 2 µm. B-D. Uptake of 20 
µg/ml transferrin-Alexa Fluor 488 was performed essentially as described for the 
FITC-dextran uptake in Fig. 2B, except the lysis step was omitted because 
transferrin-Alexa 488 is not pH sensitive. Mean fluorescence  +/- standard 
deviations is shown (n=3). Comparisons between uninduced and induced were 
performed using a 2-tailed Student’s t-test. B. Normal media (*, p=0.05). C. Low 
lipid media (*, p = 0.02). D. High lipid media (*, p=0.007).  
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Figure 2.4. ACC-RNAi Slows Kinetics of Antibody Clearance from T. brucei 
surface. Clonal BF ACC-RNAi cells displaying the VSG 221 surface coat were 
isolated by flow cytometry and then induced for ACC-RNAi for 9 days in low, 
normal, or high lipid media. Induced (+RNAi) and uninduced control (No RNAi) 
cells were incubated with  Anti-VSG 221 rabbit polyclonal antibody on ice for 30 
min., followed by the addition of goat-anti-rabbit IgG FITC conjugated secondary 
antibody on ice for 1 hour. Cells were then transferred to a 37°C fluorescence 
plate reader and the FITC signal was recorded every 2 minutes continuously for 
90 minutes at 37oC. Representative data for multiple replicates is shown (See 
Table 1). A.  Cartoon of experimental timecourse indicating the endocytosis 
(decreasing fluorescence) and exocytosis (increasing fluorescence) phases of 
the timecourse. ∆t is the total time from t=0 to the time it takes for exocytosed 
FITC-antibody to return to the initial fluorescence level before internalization. B. 
Low lipid media. C. Normal media. D. High lipid media. 
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Figure 2.5. ACC-RNAi reduces the ability of T. brucei to avoid complement-
mediated lysis. Clonal BF ACC-RNAi cells displaying the VSG 221 induced for 
ACC-RNAi for 9 days in low, normal, or high lipid media. Induced (+RNAi) and 
uninduced control (No RNAi) cells were incubated with  Anti-VSG 221 rabbit 
polyclonal antibody on ice for 30 min., followed by an incubation at 37oC for 
empirically determined timepoints (Table 1): low, 18 mins, normal, 17 mins, and 
high, 18 mins. Cells were then incubated at 37oC in the presence of guinea pig 
complement. CellTiter-Blue Reagent was added to the cell solutions, which were 
transferred to a 37°C fluorescence plate reader and th e signal was recorded after 
60 minutes of incubation at 37oC. Mean fluorescence  +/- standard deviations is 
shown (n=3). Comparisons between uninduced and induced were performed 
using a 2-tailed Student’s t-test. Normal media (*, p=0.02). Low lipid media (*, p = 
0.01). High lipid media (*, p=0.005). 
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Table 2.1: Antibody Clearance is Delayed in BF ACC-RNAi Cells After 9 
days for All Growth Conditions. 
Growth 
Medium 
ACC-
RNAi 
∆t1 +/- standard 
deviation N 
p 
value2 
Low Lipid  - 18 +/- 1.2 3 0.002 
+ 24 +/- 0.89 3 
Normal Lipid  
- 17 +/- 1.03 3 
0.002 
+ 23 +/- 1.11 3 
High Lipid  - 16 +/- 0.98 3 0.003 
+ 22 +/- 1.21 3 
1
∆t is the calculated average of time of antibody clearance via endocytosis 
and exocytosis of the surface bound FITC conjugated secondary antibody. 
2Significance of comparison of ∆t of uninduced and induced BF ACC-RNAi 
for each growth media was determined using a 2-tailed Student’s t-test. 
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ABSTRACT 
 Trypanosoma brucei, the causative agent of human African 
trypanosomiasis (HAT), is a protozoan parasite that lives extracellularly within the 
mammalian host, where it must adapt to a variety of host micro-environments 
that differ in nutrient content. T. brucei is able to supply itself with fatty acids in 
two manners: uptake from the environment or synthesis. The parasites can also 
store fatty acids in the form of neutral lipids storage within organelles known as  
lipid droplets. To begin characterizing lipid droplets in T. brucei, we examined the 
effect of environmental lipid availability on the lipid droplets. We found a 62 ± 2% 
decrease in lipid droplet number when parasites were grown in a low lipid media, 
but observed no change in lipid droplets in high lipid media. Next, we inhibited 
fatty acid synthesis through RNAi of the Acetyl-CoA Carboxylase, which 
catalyzes the first committed step in fatty acid synthesis. ACC RNAi for 3 days 
resulted in a decrease in lipid droplet number by 29 ± 5%, 34 ± 8%, and 20 ± 5% 
in normal, low, and high lipid media respectively. ACC RNAi for 9 days increased 
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this effect, reducing lipid droplet number by 57 ± 15%, 37 ± 15%, and 27 ± 4% in 
normal, low, and high lipid media, respectively. Finally, addition of exogenous 
palmitic acid (C16:0) to BF parasites induced and uninduced for ACC-RNAi 
grown in low lipid medium for 9 days to determine the effect on lipid droplet 
number. As we observed before, ACC-RNAi decreased lipid droplet number in all 
three conditions. However, exogenous addition of either a fluorescent BODIPY-
conjugated or unconjugated fatty acid, palmitate (C16:0), resulted in a greater 
than 2-fold increase in lipid droplet number. This leads us to believe that fatty 
acid synthesis, uptake, and the environmental lipid availability all act in concert to 
affect lipid droplet maintenance/biogenesis in T. brucei.  
INTRODUCTION 
 Trypanosoma brucei is an extracellular protozoan parasite vectored by the 
tse tse fly that infects both humans and livestock in sub-Saharan Africa. It causes 
human African trypanosomiasis (HAT) in humans and a wasting disease, 
nagana, in cattle. Within its hosts, T. brucei must adapt to many distinct 
environments, differing in available nutrients. For example, there are ~300X 
fewer available lipids in the cerebrospinal fluid compared to the bloodstream 
(Lentner, 1981). T. brucei has a large fatty acid requirement because they are 
constituents of glycosylphosphatidylinositol (GPI) anchors, which anchor key 
glycoproteins to the surface. The mammalian bloodstream form (BF) parasite is 
covered in variant surface glycoproteins (VSGs), each requiring two myristates 
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(Paul et al., 2001), while the insect procyclic form (PF) parasite is covered in 
procyclins, each containing two fatty acids (Acosta-Serrano et al., 2001).  
 T. brucei is able to supply itself with fatty acids in two distinct manners: de 
novo synthesis of fatty acids or uptake from the environment. Although, uptake is 
more energetically favorable, T. brucei must rely on its fatty acid synthesis (FAS) 
pathways when environmental fatty acids are limiting (Lee et al., 2006; Vigueira 
and Paul, 2011). Two FAS pathways have been described in T. brucei. The 
elongase (ELO) pathway is found in the ER and accounts for the majority (~90%) 
of de novo synthesis (Lee et al., 2006) and the mitochondrial pathway (~10%) 
(Stephens et al., 2007; Guler et al., 2008). The first committed step of fatty acid 
synthesis is the conversion of malonyl-CoA to acetyl-CoA via the enzyme acetyl-
CoA carboxylase (Tehlivets et al., 2007; Saggerson, 2008). Previously RNA 
interference (RNAi) of T. brucei ACC, demonstrated that the enzyme is 
necessary for full virulence in murine models (Vigueira and Paul, 2011). We 
hypothesize that this necessity is based on the reliance of T. brucei on fatty acids 
in host adaptation, specifically in lipid droplet maintenance/biogenesis.  
 Lipid droplets are highly dynamic lipid storage organelles found primarily 
in eukaryotes but also in some prokaryotes (Law and Wells, 1989; Packter and 
Olukoshi, 1995; Hsieh and Huang, 2005; Ashraft, 2007). Lipid droplets are 
usually composed of neutral lipids. The most common storage lipids are 
triacylglycerols and cholesterol esters, but fatty acids and diacylglycerols also 
have been identified in the core of these droplets (Martin and Parton, 2006; 
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Czabany et al., 2008; Goodman, 2008; Reue, 2011). Surrounding the neutral 
lipid core is a phospholipid monolayer membrane similar to that of the ER, with 
the acyl chains facing inward (Dvorak et al., 1994; Wan et al., 2007; Goodman, 
2009). Lipid droplets are involved in energy storage, lipid metabolism, lipid 
trafficking, and protection against toxic effects of non-esterified lipids and sterols 
(Murphy, 2001; Ozeki et al., 2005; Farese et al., 2009), but the extent of the 
involvement in all of these activities is highly specific to species, tissue, and/or 
cell type. 
 Lipid droplet synthesis and characterization in T. brucei is an unexplored 
area of research. It is unknown how lipid droplets are created and trafficked 
within the cell and what proteins may be involved in the process or colocalized 
with lipid droplets. One kinase, lipid droplet kinase (LDK), was recently found to 
be associated with lipid droplets in T. brucei. LDK is on or embedded in the 
phospholipid monolayer of the lipid droplets and is involved in both the synthesis 
and the maintenance of lipid droplets (Flaspohler et al., 2010).  
 We hypothesize that FAS, uptake, and environmental lipid concentration 
effect T. brucei lipid droplets. Since lipid droplets serve as a storage organelle 
and may be involved in trafficking, we hypothesize that newly synthesized fatty 
acids can be stored within the lipid droplets and that the lipid droplets may serve 
as a reservoir, from which the parasite can utilize fatty acids for lipid biogenesis. 
 First, we examined the environmental effect of lipid concentration on the 
lipid droplets of T. brucei. In order to manipulate the lipid concentration of the 
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media, we altered the serum levels as previously described (Vigueira and Paul, 
2011). The low lipid medium contained ~4% lipid equivalents, normal lipid 
medium ~ 12%, and high lipid medium ~22%.  We found a reduction in lipid 
droplet number after prolonged growth in the low lipid medium. Then, we utilized 
the BF ACC-RNAi cells grown in the three different lipid concentrations of media 
to further decipher the effects of environmental lipids and the loss of fatty acid 
synthesis on lipid droplet number. We found that under all conditions, there was 
a significant reduction in lipid droplet number when ACC-RNAi was induced. 
Lastly, we determined the effect of exogenous fatty acids on lipid droplet number. 
When parasites were grown in low lipid medium and then supplemented with 
palmitic acid (C16:0), there was an increase in lipid droplet number, suggesting 
that fatty acids from the environment are trafficked to the lipid droplets. In 
summary, the environmental status of lipids, FAS, and uptake are all important in 
lipid droplet maintenance.  
RESULTS 
The effect of growth medium on lipid droplet number 
 It has been previously determined that exogenous lipid content in media 
effects lipid droplet number. Growth in high lipid containing media, usually results 
in an increase in lipid droplet number or size (Tachi-Sato et al., 2002). While 
growth in low lipid media for a short period of time (<24h), also results in an 
increase in lipid droplet number or size (Flaspohler et al., 2010). We assessed 
the effect of growth medium on lipid droplet number in T. brucei. After 3 days of 
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growth in low, normal, and high lipid media, the number of lipid droplets were not 
different between parasites grown in normal and high lipid media; however, there 
was a 62±2% decrease in the number of lipid droplets of parasites grown in low 
lipid media versus normal lipid media (Fig. 2.1). We were also able to 
recapitulate the results where growth in low lipid media for ~24h increases lipid 
droplet numbers (data not shown). 
The effect of ACC-RNAi on lipid droplet number   
 The induction of ACC-RNAi knocks down protein expression in BFs (Fig. 
2.1A), but when doubling time is analyzed in BF ACC-RNAi induced and 
uninduced parasites, there is no difference in doubling rate (Fig. 2.1B). T. brucei 
is able to maintain an internal lipid store in the form of lipid droplets (Flaspohler et 
al., 2010). Since we subjected the parasites to growth in different lipid containing 
medium and reduced its capability to undergo fatty acid synthesis, we assayed 
how the lipid droplet number is affected under such conditions. In normal lipid 
medium, there is a 29±5% reduction in lipid droplet number after 3 days of 
growth and induction of ACC-RNAi, 48±11% reduction after 6 days growth and 
induction, and 57±15% reduction after 9 days of growth and induction (Fig. 3.2A). 
Similarly, there is a 34±8% reduction in lipid droplet number after 3 days of 
growth and induction of ACC-RNAi in low lipid medium, 25±18% reduction after 6 
days of growth and induction, and 40±15% reduction after 9 days of growth and 
induction (Fig. 3.2C). There is also a 20±5% reduction in lipid droplet number 
after 3 days of growth and ACC-RNAi induction in high lipid medium, 16±2% 
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reduction after 6 days of growth and induction, and 27±4% after 9 days of growth 
and induction (Fig. 3.2E).  
The effect of the addition of exogenous Fatty acids on lipid droplet number 
 We determined that long term growth in low lipid medium decreases lipid 
droplet number (Fig. 3.1). We also determined that ACC-RNAi decreases lipid 
droplet number (Fig. 3.2). Since the environment and disruption of the major de 
novo synthesis pathway decreases lipid droplet formation/maintenance, we 
examined the effect of adding back exogenous fatty acids on lipid droplet number 
on No RNAi and +RNAi parasites that were grown in low lipid medium for 6 days. 
Further, we wanted to determine where the exogenous fatty acids localize within 
the cell, specifically if they went to the lipid droplets. It was previously determined 
that BFs readily take up a Bodipy conjugated palmitic acid (Bodipy-C16) at a 
concentration of 20 µM at 37oC for 20 min (Howell and Paul, Unpublished). To be 
sure that the fatty acid component and not the Bodipy dye were being trafficked 
to lipid droplets, we incubated parasites with 20 µM unlabeled palmitic acid 
(C16:0) dissolved in methanol. There were still significant reductions in each 
condition for ACC-RNAi induced BFs, but there was a significant increase in the 
add back samples, i.e. the Bodipy-C16 and the unlabeled-C16. There was a 
227±100% increase in the Bodipy-C16 addition from uninduced low lipid medium 
and a 229±112% increase in the unlabeled-C16 addition (Fig. 3.3). Additionally, 
there was also an increase in the induced parasites, although they still had a lipid 
droplet number defect. There was a 262±100% increase in the Bodipy-C16 
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addition from the induced low lipid medium and a 260±35% increase in the 
unlabeled-C16 addition (Fig. 3.3). There were no differences between the 
Bodipy-FL only control (Bodipy conjugated to C2), methanol control, DMSO 
control, and the standard BFs grown in low lipid medium for 6 days (Fig. 3.3).    
DISCUSSION 
 Here we demonstrate that the environmental status of lipids, FAS, and 
uptake influence lipid droplet maintenance and biogenesis. Incubation in low lipid 
medium for an extended period of time (3 days or more) resulted in depleted lipid 
droplet numbers. ACC-RNAi decreased lipid droplet numbers in all lipid media. 
Further, the addition of exogenous C16 to low lipid medium increased lipid 
droplet number and demonstrated that fatty acids are trafficked to the lipid 
droplet. 
 The environmental lipid content both positively and negatively affects lipid 
droplet number. Initially, short-term exposure (up to 24 hours) to low lipid 
environment increases the lipid droplet numbers, this is due in part to the 
upregulation of FAS (Lee et al., 2006; Flaspohler et al., 2010). However, 
prolonged growth in low lipid environments depletes lipid droplets, suggesting a 
utilization of internal lipid stores to maintain lipid biogenesis (Goodman, 2008). In 
high lipid environments, there was no increase in lipid droplet numbers from 
normal lipid medium. This could be due to a threshold value of lipid droplet 
number that the cell holds constant, meaning that the cell does not need or make 
any more lipid droplets.  
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 Since environmental lipid status affects both lipid droplet number and 
FAS, we determined the effect of ACC-RNAi on lipid droplet number. ACC-RNAi 
effectively reduced the number of lipid droplets in all lipid media. Therefore, FAS 
and ACC is important in the maintenance and biogenesis of lipid droplets, 
regardless of environmental lipid status. Previously, Flaspohler et al., 
demonstrated that LDK is important in lipid droplet biogenesis and maintenance 
by demonstrating that there is a decrease in lipid droplet number even when 
environmental conditions would induce an increase (Flaspohler et al., 2010). We 
also saw a decrease in lipid droplet number in known elevating conditions. Even 
with a short exposure to low lipid medium, there was still a decrease in ACC-
RNAi parasites compared to uninduced (Data not shown). 
 Since ACC is important in lipid droplet maintenance, we hypothesize that 
lipid droplets may serve as a reservoir of fatty acids and lipids to feed into lipid 
biogenesis for production of membrane lipids and lipid signaling molecules. To 
test this hypothesis, we wanted to demonstrate that exogenous fatty acids, when 
the cell has been grown in low lipid medium for an extended period of time, are 
trafficked to lipid droplets. We did determine that exogenous fatty acids are 
brought into the cell and are eventually trafficked to lipid droplets, increasing their 
numbers. Since exogenous fatty acids are stored in lipid droplets, we 
hypothesize that fatty acids are taken up or synthesized and shuttled to the lipid 
droplet, where they can be utilized in lipid biogenesis. Other neutral lipid products 
from either uptake or synthesis may also be stored or utilized from lipid droplets. 
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Therefore, we hypothesize that lipid droplets in T. brucei are truly dynamic 
organelles that associate with the trafficking pathways, much like lipid droplets in 
yeast, adipocytes, hepatocytes, and muscle cells (Novikoff et al., 1980; 
Blanchette-Mackie et al., 1995; Murphy and Vance, 1999; Habeler et al., 2002; 
Cohen et al., 2004; Binns et al., 2006; Bartz et al., 2007; Guo et al., 2008; 
Goodman, 2008; Goodman, 2009; Reue, 2011). 
 Our preliminary data supports our hypotheses; however, we will need to 
perform some colocalization assays to further prove that fatty acids are trafficked 
to lipid droplets. We also need to complete live cell imaging to solidify the 
trafficking pattern into and within the cell of our fatty acids. And lastly, we will 
need to determine the changes if any in bulk lipid synthesis to connect FAS and 
lipid droplet depletion to bulk lipid synthesis. 
 Lipid droplets are becoming more important in biomedical research. Some 
cancer cells present larger, more numerous lipid droplets. Additionally, diabetes 
research and muscular disorders research are also highly interested in lipid 
droplet biology (Dvorak et al., 1983; Murphy, 2001; Melo et al., 2011; Haemmerle 
et al., 2011). Lipid droplets become increasingly interesting in T. brucei because 
their primary usage is obsolete within the parasite. Although T. brucei possesses 
the machinery to undergo β-oxidation, no one has described the process in BFs. 
The only energy metabolism that occurs in BFs is glycolysis. Therefore, T. brucei 
offers a unique study organism for lipid droplet biology. Since it does not utilize 
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lipid droplets as an energy storage, it could be easier to determine their roles in 
the trafficking pathways in the cell and associations to other organelles.  
Future Directions 
 In the future, I suggest we begin to delve into the relationship between 
FAS and lipid droplet maintenance in and biogenesis by doing some studies with 
the LDK mutant lines from Dr. Parson’s group. We need to investigate ACC 
levels and phosphorylation states in the LDK-RNAi lines to determine if the two 
pathways work in concert or antagonistically.  
 Currently, we are investigating other potential proteins that could be 
involved in lipid droplet maintenance by screening the RNAi library available in 
PFs. If we can find other proteins involved in lipid droplet maintenance, we 
should also look at ACC levels and phosphorylation to determine linkage 
between the pathways.  
 More interestingly, we made a preliminary connection between fatty acid 
uptake and lipid droplet maintenance. We demonstrated that exogenous 
fluorescently tagged fatty acids do become incorporated into lipid droplets. 
However, we should conduct live cell imaging with our Bodipy tagged C16 to 
further illucidate the downstream uptake pathway, i.e. can we track fluorescent 
C16 through the edocytic pathway to the ER and then the lipid droplet and 
beyond?  
 Lastly, we should determine the effect of lipid droplet depletion and ACC-
RNAi on bulk lipid synthesis in the cell. I began a preliminary experiment with this 
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utilizing a “cold” TLC method. We should move on to “hot” TLC, utilizing 3H fatty 
acids to track lipid biogenesis and determine the differences if any in our ACC-
RNAi lines and environmental effects on bulk lipid synthesis.  
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MATERIALS AND METHODS 
Reagents 
 All chemicals and reagents used in these studies were purchased from 
Thermo Fisher Scientific and Sigma except Iscove’s Modified Dulbecco’s 
Medium (IMDM), Bodipy conjugated fatty acids (C16:0 and C2:0), and 4’-6-
diamidino-2-phenylindole (DAPI) (Invitrogen), Serum Plus (JRH Biosciences), 
delipidated fetal bovine serum (FBS) (Cocalico BIologicals), and poly-L-lysine 
solution (Electron Microscopy Sciences). 
 Trypanosome Strains and Cell Lines 
 Previously, BF and PF ACC-RNAi cell lines were generated as described 
from BF 90-13 cell lines or PF 29-13 cell lines (Wang et al., 2000; Morris et al., 
2001; Vigueira and Paul, 2011). The BF 90-13 ACC-5 cell lines were grown in 
HMI-9 medium (Hirumi and Hirumi, 1989) containing 10% heat-inactivated 
FBS/10% Serum Plus and supplemented with 2.5 µg/ml G418, 5 µg/ml 
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hygromycin, and 2.5 µg/ml phleomycin. PF ACC-RNAi cell lines were grown in 
SDM-79 medium (Brun and Shonenberger, 1979) containing 10% heat-
inactivated FBS and supplemented with 15 µg/ml G418, 50 µg/ml hygromycin, 
and 2.5 µg/ml phleomycin. 
Streptavidin Blotting  
 Hypotonic lysates were prepared as previously described (Morita et al., 
2000). Streptavidin blotting can detect the biotin prosthetic group on ACC and 
was performed essentially as described (Vigueira et al., 2011). Briefly, the 
lysates were fractionated on 10% SDS-PAGE gels, transferred to nitrocellulose, 
and blocked in Wash Buffer (1% dry milk, 1X TBS, 0.05% Tween-20). The blot 
was then cut; the top was half probed for ACC with SA-HRP and the bottom for 
tubulin. The blot was probed for ACC with streptavidin-horseradish peroxidase 
conjugate (1:400 in 0.2% dry milk, 1X Tris-buffered saline (TBS), 0.05% Tween-
20). The lower portion was probed for tubulin with a mouse anti-tubulin antibody 
(clone B-5-1-2) diluted 1:50,000 in Wash Buffer followed by HRP-conjugated 
goat anti-mouse IgG antibody (Invitrogen) diluted 1:10,000 in Wash Buffer. Semi-
quantitative analysis of the blots was performed using densitometry (NIH Image J 
software) of exposed films (unsaturated signal within the linear range of the film).  
Growth Curves  
 Bloodstream form ACC-RNAi cells were diluted into normal, low, or high 
lipid media at 104 cells/mL, induced by the addition of tetracycline (1 µg/mL final) 
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(Wang et al., 2000), and cell density monitored using a hemocytometer. For 
comparison, the slopes of the growth curves (linear correlation coefficients) were 
derived from linear regressions performed using Microsoft Excel. Doubling times 
were calculated from the slopes. 
Preparation of Low Lipid and High Lipid Medias 
 As previously reported, the only source of lipids in media is from the 
serum additives (Vigueira and Paul, 2011). Serum Plus and delipidated FBS 
contain ~20% serum lipids. Low-lipid HMI-9 media was prepared with 10% 
Serum Plus and 10% delipidated FBS. The resulting media contain serum lipids 
equivalent to 4% (Vigueira and Paul, 2011). High-lipid HMI-9 media was 
prepared with 10% Serum Plus and 20% FBS, resulting in a media containing 
serum lipids equivalent to 22% (Vigueira and Paul, Unpublished?). Low lipid 
medium was prepared with 10% delipidated FBS, and contained serum lipids 
equivalent to 2% FBS, compared to 10% for the normal SDM-79 (Vigueira and 
Paul, 2011). High lipid medium was prepared with 20% FBS, and contained 
serum lipids equivalent to 20% FBS. 
Lipid Droplet Microscopy 
 Microscopy was performed essentially as described in (Field et al., 2004). 
Briefly, BF ACC-RNAi uninduced and induced cells were grown in normal, low, 
and high lipid media for 3, 6, or 9 days. They were harvested by centrifugation 
(800 x g, 10 min) and washed 1 time in ice-cold Voorheis’s modified PBS (vPBS) 
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(Nolan et al., 2000). The cells were fixed on ice in 1.5% paraformaldehyde (w/v) 
in vPBS for 10 minutes. Fixed parasites were adhered to poly-L-lysine treated 
glass slides and permeabilized for 10 minutes in 0.1% Triton X-100 (v/v) in vPBS. 
The cells were then incubated with 0.05% Nile Red diluted in vPBS (Greenspan 
et al., 1985; Robibaro et al., 2002). The fluorescence of Nile Red is more specific 
to lipid droplets in the FITC channel (528 nm); therefore, data collected was done 
so in the green channel (Listenberger, et al., 2007; Flaspohler et al., 2010). For 
Bodipy-C16 uptake experiments, microscopy was performed essentially the 
same; however, the cells were pre-incubated before fixation with vPBS only 
control, 20 µM methanol only control, 20 µM DMSO only control, 20 µM Bodipy-
C16 in vPBS, 20 µM Bodipy-FL in vPBS, or 20 µM unlabeled C16:0 dissolved in 
ethanol. The nucleus and kinetoplast were stained with 4’-6-diamidino-2-
phenylindole (DAPI) (1 mg/mL in vPBS) (Invitrogen) (Field et al., 2004). Lipid 
droplets were counted per nuclei for 100 nuclei. These assays were repeated 3 
times. Student t-tests were performed utilizing Microsoft Excel. Images were 
collected using a Nikon TE2000 widefield epifluorescence microscope and image 
acquisition was performed using Nikon NIS Elements software package. Image 
analysis was further performed using NIH Image J and Adobe Photoshop. 
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Figure 3.1. Exogenous Lipid Content Affects the Number of Internal Lipid 
Droplets. Fixed and permeabilized BFs were stained with Nile Red to detect lipid 
droplets and with 4’,6’-diamidino-2-phenylindole (DAPI) to stain nuclei and 
kinetoplast DNA (kDNA) and imaged as described (Robibaro et al., 2002 and 
Field et al., 2004). The number of lipid droplets per nucleus were counted and 
the average value ± standard deviation is shown  (100 nuclei, n=3). *, p<0.0001, 
2-tailed Student’s t-test, low vs. normal. 
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Figure 3.2. ACC-RNAi Decreases the Number of Lipid Droplets in T. brucei 
in All Growth Conditions. BF ACC-RNAi cells were grown in normal, low, or 
high lipid media and induced for ACC-RNAi for 3, 6, or 9 days. Induced (+ RNAi) 
and uninduced controls (No RNAi) were stained with Nile Red (lipid droplets) and 
DAPI (nuclei and kDNA) as described in Fig. 2. A, C, and E. Average lipid 
droplet per nucleus ± standard deviation (100 nuclei, n=3). Statistical 
comparisons between uninduced and induced were performed using 2-tailed 
Student’s t-test. A. ACC RNAi induction in normal media (**, p<0.0001). C. ACC 
RNAi induction in low lipid media (*, p=0.002; **, p<0.0001). E. ACC RNAi 
induction in high lipid media (**, p<0.0001). B, D, and F. Representative 
microscopy for each a 9 day ACC RNAi induction in each growth medium. 
Phase/DAPI overlay (left) and Nile red fluorescence (right) are shown. Scale bar 
= 2 µm. B. Normal media. D. Low lipid media. F. High lipid media. 
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Figure 3.3. Addition of Exogenous Palmitic Acid (C16:0) Increases Lipid 
Droplet Number. BF ACC-RNAi cells grown in low lipid media were induced for 
ACC-RNAi for 9 days. Induced (+ RNAi) and uninduced control (No RNAi) cells 
were incubated with no fatty acid, 20 µM unlabeled C16 in ethanol, 20 µM 
Bodipy-FL, or 20 µM Bodipy conjugated C16 for 20 minutes at 37oC. Cells were 
then imaged and lipid droplet number per nucleus determined as described in 
Fig. 2 (100 nuclei, n=3).  A. Average lipid droplets per nuclei are shown ±  
standard deviations. Comparisons between uninduced and induced were 
performed using a 2-taile Student’s t-test.  B. Representative microscopy of each 
condition. Phase/DAPI overlay and Nile red fluorescence are shown. Scale bar 2 
µm. 
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CHAPTER 4 
CONCLUSIONS 
 Lipid metabolism in Trypanosoma brucei is a unique and essential 
process, which makes it an excellent metabolic pathway to study. The parasite’s 
major de novo synthesis pathway found in the ER, utilizing a series of 
microsomal elongases, is novel, and many of the characterized genes represent 
potential drug targets. Since there is a plethora of gene targets to explore in this 
pathway, it is surprising that lipid metabolism remains an understudied subject in 
T. brucei.  
 The research that I have presented in this thesis has added to our 
knowledge of lipid metabolism in T. brucei. I have elucidated a novel role for 
acetyl-CoA carboxylase (ACC) in virulence, specifically the upregulation of 
endocytosis to clear surface immune antigens. However, we did not attempt to 
describe the role of ACC in antigenic variation. In the future, variant surface 
glycoprotein (VSG) presentation on the cell surface and switching should be 
determined in ACC mutants to further define the role of ACC in virulence. It may 
also be interesting to harvest trypanosomes from mice infected with the ACC 
mutant lines and compare the populations’ VSG heterogeneity to that of mice 
infected with control parasites to determine if there is a difference in switch rates 
in vivo. If we can connect reduction of ACC activity to a reduction in multiple 
immune evasion tactics, targeting this enzyme could become a fruitful endeavor 
as a potential drug target. 
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 Not only did we investigate the role of ACC in virulence, we also started to 
characterize lipid droplet biology in T. brucei. Only one study on lipid droplets in 
T. brucei is published. My studies linked fatty acid synthesis, environmental lipid 
availability, and fatty acid uptake to lipid droplet dynamics. Because lipid droplets 
could serve as an important source of lipids for the parasite, especially in low 
lipid environments (i.e. cerebrospinal fluid), elucidating the role of these lipid 
stores in vivo could help us to understand the parasite’s ability to adapt to its 
host.  
 There are also a number of other reasons to study lipid droplets. They are 
becoming increasingly important in other branches of biomedical research, i.e. 
cancer, diabetes, energy acquisition in muscle cells during rest and exercise, and 
neurological messaging/ myelin sheath repair research. Since all eukaryotic cells 
and some prokaryotes possess lipid droplets, they are a dynamic and diverse 
organelle to study. To better understand lipid droplets in T. brucei, the lab has 
initiated an undergraduate research project on lipid droplets under my 
supervision. We are screening the RNAi library for other genes linked to lipid 
droplet maintenance/biogenesis in T. brucei. This screen will allow us to begin 
unraveling the molecular and regulatory mechanisms mediating lipid droplet 
biology within the African trypanosome.  
 As for other future endeavors, another important line of investigation will 
be to examine fatty acid uptake in T. brucei. Because T. brucei is able to supply 
itself with fatty acids through both uptake and synthesis, I believe it is important 
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to examine these two acquisition mechanisms in tandem. If fatty acid synthesis 
or uptake provides a drug target, certainly there should be a two-pronged attack 
targeting both parts of the supply chain. 
 I hope that this thesis provides useful information for future researchers 
interested in T. brucei.  I believe that the continuation in defining lipid metabolism 
in T. brucei could help to bring forth a cure for a devastating disease that has too 
longed plagued sub-Saharan Africa.  
 
